Optimizing component formula suppresses lung cancer by blocking DTL-mediated PDCD4 ubiquitination to regulate the MAPK/JNK pathway
Open Access
- 1 December 2022
- journal article
- research article
- Published by Elsevier BV in Journal of Ethnopharmacology
- Vol. 299, 115546
- https://doi.org/10.1016/j.jep.2022.115546
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- The Role of Traditional Chinese Herbal Medicines in Cancer Therapy – from TCM Theory to Mechanistic InsightsPlanta Medica, 2010
- CRL4s: the CUL4-RING E3 ubiquitin ligasesTrends in Biochemical Sciences, 2009
- Signal integration by JNK and p38 MAPK pathways in cancer developmentNature Reviews Cancer, 2009
- Systematic and integrative analysis of large gene lists using DAVID bioinformatics resourcesNature Protocols, 2008
- PCNA-dependent regulation of p21 ubiquitylation and degradation via the CRL4Cdt2 ubiquitin ligase complexGenes & Development, 2008
- Suppression of p53-dependent senescence by the JNK signal transduction pathwayProceedings of the National Academy of Sciences of the United States of America, 2007
- DTL/CDT2 is essential for both CDT1 regulation and the early G2/M checkpointJournal of Bone and Joint Surgery, 2006
- CUL4–DDB1 ubiquitin ligase interacts with multiple WD40-repeat proteins and regulates histone methylationNature, 2006
- Molecular architecture and assembly of the DDB1–CUL4A ubiquitin ligase machineryNature, 2006
- Glide: A New Approach for Rapid, Accurate Docking and Scoring. 2. Enrichment Factors in Database ScreeningJournal of Medicinal Chemistry, 2004